Literature DB >> 22237935

Microparticles as autoantigens: making immune complexes big.

David S Pisetsky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22237935      PMCID： PMC3724462          DOI： 10.1002/art.34377

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  17 in total

1.  Platelets amplify inflammation in arthritis via collagen-dependent microparticle production.

Authors:  Eric Boilard; Peter A Nigrovic; Katherine Larabee; Gerald F M Watts; Jonathan S Coblyn; Michael E Weinblatt; Elena M Massarotti; Eileen Remold-O'Donnell; Richard W Farndale; Jerry Ware; David M Lee
Journal:  Science       Date:  2010-01-29       Impact factor: 47.728

Review 2.  Plasma membrane repair and cellular damage control: the annexin survival kit.

Authors:  Annette Draeger; Katia Monastyrskaya; Eduard B Babiychuk
Journal:  Biochem Pharmacol       Date:  2011-01-08       Impact factor: 5.858

Review 3.  The role of defective clearance of apoptotic cells in systemic autoimmunity.

Authors:  Luis E Muñoz; Kirsten Lauber; Martin Schiller; Angelo A Manfredi; Martin Herrmann
Journal:  Nat Rev Rheumatol       Date:  2010-05       Impact factor: 20.543

4.  Endothelial dysfunction in systemic lupus patients with low disease activity: evaluation by quantification and characterization of circulating endothelial microparticles, role of anti-endothelial cell antibodies.

Authors:  Arnaud Duval; Dominique Helley; Loïc Capron; Pierre Youinou; Yves Renaudineau; Sylvain Dubucquoi; Anne-Marie Fischer; Eric Hachulla
Journal:  Rheumatology (Oxford)       Date:  2010-03-07       Impact factor: 7.580

5.  Plasma platelet-derived microparticles in patients with connective tissue diseases.

Authors:  Chinami Oyabu; Akio Morinobu; Daisuke Sugiyama; Jun Saegusa; Shino Tanaka; Sahoko Morinobu; Goh Tsuji; Shimpei Kasagi; Seiji Kawano; Shunichi Kumagai
Journal:  J Rheumatol       Date:  2011-01-15       Impact factor: 4.666

6.  Microparticles as antigenic targets of antibodies to DNA and nucleosomes in systemic lupus erythematosus.

Authors:  Anirudh J Ullal; Charles F Reich; Megan Clowse; Lisa G Criscione-Schreiber; Martin Tochacek; Marc Monestier; David S Pisetsky
Journal:  J Autoimmun       Date:  2011-03-03       Impact factor: 7.094

Review 7.  The role of microparticles in the pathogenesis of rheumatic diseases.

Authors:  Christian Beyer; David S Pisetsky
Journal:  Nat Rev Rheumatol       Date:  2009-12-01       Impact factor: 20.543

Review 8.  Death-associated protein kinase (DAPK) and signal transduction: blebbing in programmed cell death.

Authors:  Miia Bovellan; Marco Fritzsche; Craig Stevens; Guillaume Charras
Journal:  FEBS J       Date:  2009-10-30       Impact factor: 5.542

Review 9.  Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles.

Authors:  Bence György; Tamás G Szabó; Mária Pásztói; Zsuzsanna Pál; Petra Misják; Borbála Aradi; Valéria László; Eva Pállinger; Erna Pap; Agnes Kittel; György Nagy; András Falus; Edit I Buzás
Journal:  Cell Mol Life Sci       Date:  2011-05-11       Impact factor: 9.261

10.  Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity.

Authors:  Jérémie Sellam; Valérie Proulle; Astrid Jüngel; Marc Ittah; Corinne Miceli Richard; Jacques-Eric Gottenberg; Florence Toti; Joelle Benessiano; Steffen Gay; Jean-Marie Freyssinet; Xavier Mariette
Journal:  Arthritis Res Ther       Date:  2009-10-15       Impact factor: 5.156
View more
  10 in total

1.  Urinary extracellular vesicle-associated MCP-1 and NGAL derived from specific nephron segments differ between calcium oxalate stone formers and controls.

Authors:  Robin S Chirackal; Muthuvel Jayachandran; Xiangling Wang; Samuel Edeh; Zejfa Haskic; Majuran Perinpam; Timothy M Halling; Ramila Mehta; Marcelino E Rivera; John C Lieske
Journal:  Am J Physiol Renal Physiol       Date:  2019-08-28

Review 2.  Emerging role of extracellular vesicles in inflammatory diseases.

Authors:  Edit I Buzas; Bence György; György Nagy; András Falus; Steffen Gay
Journal:  Nat Rev Rheumatol       Date:  2014-02-18       Impact factor: 20.543

3.  Plasma ficolin levels and risk of nephritis in Danish patients with systemic lupus erythematosus.

Authors:  Nima Tanha; Katrine Pilely; Mikkel Faurschou; Peter Garred; Søren Jacobsen
Journal:  Clin Rheumatol       Date:  2016-12-15       Impact factor: 2.980

4.  Innate and humoral recognition of the products of cell death: differential antigenicity and immunogenicity in lupus.

Authors:  P Arora; M Malik; R Sachdeva; L Saxena; J Das; V G Ramachandran; R Pal
Journal:  Clin Exp Immunol       Date:  2016-12-05       Impact factor: 4.330

Review 5.  The non-haemostatic role of platelets in systemic lupus erythematosus.

Authors:  Petrus Linge; Paul R Fortin; Christian Lood; Anders A Bengtsson; Eric Boilard
Journal:  Nat Rev Rheumatol       Date:  2018-03-21       Impact factor: 20.543

6.  The role of antigen specificity in the binding of murine monoclonal anti-DNA antibodies to microparticles from apoptotic cells.

Authors:  Anirudh J Ullal; Tony N Marion; David S Pisetsky
Journal:  Clin Immunol       Date:  2014-05-27       Impact factor: 3.969

Review 7.  Toward a new autoantibody diagnostic orthodoxy: understanding the bad, good and indifferent.

Authors:  Marvin J Fritzler
Journal:  Auto Immun Highlights       Date:  2012-03-21

Review 8.  Pro-Thrombotic Activity of Blood Platelets in Multiple Sclerosis.

Authors:  Joanna Saluk-Bijak; Angela Dziedzic; Michal Bijak
Journal:  Cells       Date:  2019-02-01       Impact factor: 6.600

Review 9.  Microparticles That Form Immune Complexes as Modulatory Structures in Autoimmune Responses.

Authors:  Catalina Burbano; Mauricio Rojas; Gloria Vásquez; Diana Castaño
Journal:  Mediators Inflamm       Date:  2015-08-02       Impact factor: 4.711

Review 10.  Modulating Cytokine Production via Select Packaging and Secretion From Extracellular Vesicles.

Authors:  Betsy J Barnes; Carter C Somerville
Journal:  Front Immunol       Date:  2020-05-29       Impact factor: 7.561
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.